acalabrutinib
Showing 76 - 86 of 86
Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Acalabrutinib
-
Chandler, Arizona
- +107 more
Mar 8, 2022
Lymphoma, Mantle Cell Trial in Worldwide (Acalabrutinib, Bendamustine, Rituximab)
Recruiting
- Lymphoma, Mantle Cell
- Acalabrutinib
- +3 more
-
Downey, California
- +231 more
Jan 16, 2023
Advanced Haematological Malignancies Trial in Worldwide (AZD4573, Acalabrutinib)
Recruiting
- Advanced Haematological Malignancies
- AZD4573
- Acalabrutinib
-
Duarte, California
- +38 more
Jul 22, 2022
Non-hodgkin Lymphoma,B Cell Trial in Seoul (Acalabrutinib)
Unknown status
- Non-hodgkin Lymphoma,B Cell
- Acalabrutinib
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 17, 2019
NSCLC Trial in Goodyear (Pembrolizumab, Acalabrutinib)
Completed
- Carcinoma, Non-Small-Cell Lung
- Pembrolizumab
- Acalabrutinib
-
Goodyear, ArizonaWestern Regional Medical Center/Cancer Treatment Center of Ameri
Aug 22, 2019
Richter Syndrome Trial (Acalabrutinib, Cyclophosphamide, Doxorubicin)
Not yet recruiting
- Richter Syndrome
- Acalabrutinib
- +5 more
- (no location specified)
Mar 31, 2019
Rheumatoid Arthritis Trial in United States (acalabrutinib, Placebo)
Completed
- Rheumatoid Arthritis
- acalabrutinib
- Placebo
-
Anniston, Alabama
- +16 more
Mar 25, 2019
Mantle Cell Lymphoma Trial (acalabrutinib, ibrutinib, rituximab)
Withdrawn
- Mantle Cell Lymphoma
- acalabrutinib
- +2 more
- (no location specified)
May 12, 2016